Vacuum Assisted Wound Closure and Permanent On-lay Mesh-mediated Fascial Traction in Patients With Open Abdomen
Launched by SKANE UNIVERSITY HOSPITAL · Sep 30, 2022
Trial Information
Current as of November 13, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new method for treating patients with an open abdomen, which is a situation where the abdominal cavity cannot be safely closed after surgery or injury. The new technique combines vacuum-assisted wound closure and a special mesh to help close the abdomen while reducing the risk of hernias (bulges that can occur at the incision site). The goal is to see if this method leads to fewer hernias compared to other treatments that have been used in the past.
To participate in this trial, you must be at least 18 years old and have an open abdomen with a midline incision. However, you won't be able to join if you already have a hernia, have had mesh placed in your abdomen, or if you have certain other conditions. If you take part, you can expect to be monitored closely to assess your recovery and any complications over time. It's important to know that this trial is still in the planning stages, so participants are not yet being recruited.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • All patients ≥18 years old treated with an open abdomen with a midline incision, regardless of indication.
- Exclusion Criteria:
- • Patient declining participation
- • Existing incisional hernia or primary ventral hernia ≥3 cm
- • Existing mesh in the abdominal wall, located in the midline and irrespective of mesh size
- • Existing ostomy/parastomal hernia located in a position that prevents the VAWCPOM technique to be utilized
- • Closure of the abdomen at first dressing change, e. g. without mesh traction
About Skane University Hospital
Skåne University Hospital is a leading academic medical center located in Sweden, renowned for its commitment to advancing healthcare through innovative clinical research and trials. As a key player in the Nordic healthcare landscape, the hospital integrates cutting-edge medical practices with rigorous scientific inquiry, aiming to improve patient outcomes and foster advancements in medical knowledge. With a multidisciplinary approach, Skåne University Hospital collaborates with various stakeholders, including universities and research institutions, to conduct high-quality clinical trials that address critical health challenges and contribute to the development of new treatments and therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Ulf Pettersson, Ass prof
Principal Investigator
Lund University, Sweden. Department of Surgery Skane university hospital, Sweden
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials